Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
1 other identifier
observational
70
1 country
1
Brief Summary
This study looks at how well a combination of treatments helps reduce pain in people with tumors in the middle and lower back (thoracic and lumbar spine). All participants receive the same treatment, which includes a procedure to stabilize the spine (kyphoplasty), radiofrequency ablation will be with the Osteocool system and radiation therapy. The goal is to see how effective this combined approach is at relieving pain. The purpose of this study is to find out whether combining these three treatments provides better pain relief for patients with thoracic and lumbar spine tumors. This study is for adults who have cancer that has spread to the thoracic or lumbar spine and who report moderate to severe back pain (a pain score of 5 or higher on a 0-10 pain scale).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2026
CompletedStudy Start
First participant enrolled
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2031
April 23, 2026
April 1, 2026
5 years
March 12, 2026
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain intensity
Change in pain intensity will be measured using visual analog scale (VAS) assessments, from baseline (pre-therapy) to 1 month post completion of radiotherapy.
Baseline and at 3 months (1 months after completion of radiotherapy)
Secondary Outcomes (8)
Presence of thoracic and lumbar spine tumors
at 3- and 6-months following procedure
Long term new or worsened vertebral body compression fracture
at 6 months following procedure
Retreatment of thoracic and lumbar spine tumor
at 6 months following procedure
Quality of life per Patient-Reported Outcomes version of the Common Terminology Criteria
Baseline and at 6 months following procedure
Pain level
Baseline and at 6 months following procedure
- +3 more secondary outcomes
Study Arms (1)
Metastatic thoracic or lumbar spine tumor
metastatic thoracic or lumbar spine tumor and reported back pain of ≥ 5 on a visual analog scale (VAS) assessments scale.
Interventions
Participants will receive kyphoplasty with Osteocool prior to their Standard of Care External Beam Radiotherapy.
Eligibility Criteria
Patient with metastatic thoracic and lumbar spine tumors treated at UNC Chapel Hill
You may qualify if:
- Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
- Subjects is willing and able to comply with study procedures based on the judgement of the investigator.
- Age ≥ 18 years at the time of consent.
- Life expectancy beyond completion of protocol intervention of at least 1 month and deemed appropriate for treatment based on multidisciplinary review and/or investigator discretion.
- Metastatic thoracic or lumbar spine tumor. Tumor should be lytic or mixed lytic/blastic. Note: there does not need to be a fracture.
- Patient reported back pain of ≥ 5 on a VAS scale
You may not qualify if:
- Active infection requiring systemic therapy.
- Pregnant or breastfeeding (NOTE: breast milk cannot be stored for future use while the mother is being treated on study).
- Is currently taking Avastin or anti-coagulant meds that cannot be held.
- Is currently enrolled in a cancer related clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UNC Lineberger Comprehensive Cancer Centerlead
- Medtroniccollaborator
Study Sites (1)
UNC Hospitals
Chapel Hill, North Carolina, 27599, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicole A Keefe
UNC Lineberger Comprehensive Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2026
First Posted
March 18, 2026
Study Start
March 16, 2026
Primary Completion (Estimated)
March 1, 2031
Study Completion (Estimated)
March 1, 2031
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
Deidentified individual participant data will be available beginning 1 year after publication. Access will be granted to researchers with a methodologically sound proposal. Requests should be submitted to the corresponding investigator and may require a data use agreement.